Sign inJoin waitlistJoin the waitlist

CS

Charles Simone

Chief Medical Officer, New York Proton Center · New York Presbyterian Hospital

Credentials: · · · · ·

History

Memorial Hospital for Cancer and allied Diseases
2019–Present

National Cancer Institute
2007–2011
Preliminary or Transitional Year
2006–2007
The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania
2002–2006

Research

Use of proteomic patterns in serum to identify ovarian cancer
The Lancet · 2002 · 2,071 citations
Serum proteomic patterns for detection of prostate cancer
Journal of the National Cancer Institute · 2002 · 472 citations
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline
Practical Radiation Oncology · 2017 · 380 citations

IC
Isabelle Choi
96 papers
AR
Andreas Rimner
61 papers
Arpit Chhabra
57 papers · 1 as a resident
SH
Shaakir Hasan
47 papers · 8 as a resident
Annemarie Shepherd
44 papers · 2 as a resident
Keith Cengel
44 papers
AW
Abraham Wu
38 papers
Daniel Gomez
37 papers
DG
Daphna Gelblum
37 papers
NS
Narek Shaverdian
35 papers
Abigail Berman
34 papers · 1 as a resident
RP
Robert Press
33 papers · 20 as a fellow

Clinical trials

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 3
NRG Oncology
2023–2036
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2021–2026
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2027